You get what you measure: evaluating endpoints in MS clinical trials.
Marrie
Ruth Ann
RA
D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards*; D023381:Endpoint Determination / Q000379:methods / Q000592:standards*; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D015203:Reproducibility of Results; D016896:Treatment Outcome
D007155:Immunologic Factors